KODIAK SCIENCES INC. Preferred Stock, Shares Outstanding
KODIAK SCIENCES INC. (KOD) had Preferred Stock, Shares Outstanding of 0 shares as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-03-31
- 2025-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2024-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2024-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-31 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-31 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-15 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-28 |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-10 |
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-09 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-01 |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |